[HTML][HTML] Chemotherapy and transplantation: the role of immunosuppression in malignancy and a review of antineoplastic agents in solid organ transplant recipients

JC Krisl, VP Doan - American Journal of Transplantation, 2017 - Elsevier
It is estimated that solid organ transplant recipients have a two-to fourfold greater overall risk
of malignancy than the general population. Some of the most common malignancies after …

Epstein–Barr virus and renal transplantation

J Le, CM Durand, I Agha, DC Brennan - Transplantation reviews, 2017 - Elsevier
Epstein–Barr virus (EBV) is a gamma herpesvirus associated with diseases ranging from
asymptomatic viremia to post-transplant malignancies in kidney transplant recipients. EBV …

Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients

R Bishnoi, R Bajwa, AJ Franke, WP Skelton… - … Hematology & Oncology, 2017 - Springer
Background Post-transplant lymphoproliferative disorder is a well-recognized but rare
complication of hematopoietic stem cell and solid organ transplant. Due to rarity of this …

A French cohort study of kidney retransplantation after post-transplant lymphoproliferative disorders

S Caillard, E Cellot, J Dantal, O Thaunat… - Clinical Journal of the …, 2017 - journals.lww.com
Results We identified a total of 52 patients with kidney transplants who underwent 55
retransplantations after post-transplant lymphoproliferative disorder. The delay from post …

Post-transplant lymphoproliferative disorder after solid-organ transplant in children

MJ Absalon, RA Khoury, CL Phillips - Seminars in Pediatric Surgery, 2017 - Elsevier
The post-transplant lymphoproliferative disorders (PTLD) are a diverse group of potentially
life-threatening conditions affecting organ transplant recipients. PTLD arises in the setting of …

Immunotherapy for infectious diseases in haematological immunocompromise

MT Cutino‐Moguel, C Eades, K Rezvani… - British journal of …, 2017 - Wiley Online Library
Opportunistic infections remain a major problem across a broad spectrum of
immunocompromised haematological patient groups, with viruses, bacteria, fungi and …

Risk factors, diagnosis, and management of posttransplant lymphoproliferative disorder: improving patient outcomes with a multidisciplinary treatment approach

K Ligeti, LP Müller, C Müller-Tidow… - Transplant Research and …, 2017 - Taylor & Francis
Posttransplant lymphoproliferative disease (PTLD) is a major complication after solid organ
transplantation and allogeneic hematopoietic stem cell transplantation. The spectrum of …

[HTML][HTML] Posttransplant lymphoproliferative disorder after clinical islet transplantation: report of the first two cases

A Peters, T Olateju, J Deschenes… - American Journal of …, 2017 - Elsevier
We report the first two cases of posttransplant lymphoproliferative disorder (PTLD) in
recipients of islet transplants worldwide. First, a 44-year-old recipient of three islet infusions …

Posttransplant lymphoproliferative disorder: otolaryngological manifestations and management

R Heyes, DW Northfelt, DG Lott - Otolaryngology–Head and …, 2017 - journals.sagepub.com
Objective Posttransplant lymphoproliferative disorder (PTLD) is a unifying term for a
spectrum of lymphoid expansion entities brought about by immunosuppression and is …

[HTML][HTML] Síndrome linfoproliferativo en el trasplante hepático

M Rubio-Manzanares-Dorado… - Revista Española de …, 2017 - SciELO Espana
Introduction: Post-transplant lymphoproliferative syndrome (PTLD) is a rare and potentially
life-threatening complication after liver transplantation. The aim of this study was to analyze …